Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Bejon

Showing results (171-180 of 276) with videos related to

Pageof 28
Sort By:
BMC Infectious Diseases|February 19, 2021
Endemic chikungunya fever in Kenyan children: a prospective cohort studyDoris K Nyamwaya, Mark Otiende, Donwilliams O Omuoyo, et al.
Immunity|September 20, 2005
Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infectionMichael Walther, Jon Eric Tongren, Laura Andrews, et al.
Wellcome Open Research|October 3, 2023
The CINAMR (Clinical Information Network-Antimicrobial Resistance) Project: A pilot microbial surveillance using hospitals linked to regional laboratories in Kenya: Study ProtocolSamuel Akech, Brian Nyamwaya, Jackline Gachoki, et al.
Science Translational Medicine|July 20, 2022
Improving the diagnosis of severe malaria in African children using platelet counts and plasma <i>Pf</i>HRP2 concentrationsJames A Watson, Sophie Uyoga, Perpetual Wanjiku, et al.
Wellcome Open Research|July 7, 2023
Mortality in rural coastal Kenya measured using the Kilifi Health and Demographic Surveillance System: a 16-year descriptive analysisMark Otiende, Evasius Bauni, Amek Nyaguara, et al.
Open Forum Infectious Diseases|March 20, 2026
Longitudinal Epidemiology and Variant Dynamics of SARS-CoV-2 in Coastal Kenya (2020-2025): Clinical Features and Wave PatternsArnold W Lambisia, Joyce Nyiro, George Githinji, et al.
Molecular Biology and Evolution|September 8, 2020
Evaluating the Performance of Malaria Genetics for Inferring Changes in Transmission Intensity Using Transmission ModelingOliver J Watson, Lucy C Okell, Joel Hellewell, et al.
BMC Medicine|July 12, 2014
A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccineMichael T White, Philip Bejon, Ally Olotu, et al.
Emerging Infectious Diseases|September 14, 2023
New SARS-CoV-2 Omicron Variant with Spike Protein Mutation Y451H, Kilifi, Kenya, March-May 2023Mike J Mwanga, Arnold W Lambisia, John Mwita Morobe, et al.
The Lancet. Infectious Diseases|April 9, 2018
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort studyAngela Huttner, Selidji Todagbe Agnandji, Christophe Combescure, et al.
Pageof 28

Showing results (171-180 of 276) with videos related to

Sort By:
Pageof 28
BMC Infectious Diseases|February 19, 2021
Endemic chikungunya fever in Kenyan children: a prospective cohort studyDoris K Nyamwaya, Mark Otiende, Donwilliams O Omuoyo, et al.
Immunity|September 20, 2005
Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infectionMichael Walther, Jon Eric Tongren, Laura Andrews, et al.
Wellcome Open Research|October 3, 2023
The CINAMR (Clinical Information Network-Antimicrobial Resistance) Project: A pilot microbial surveillance using hospitals linked to regional laboratories in Kenya: Study ProtocolSamuel Akech, Brian Nyamwaya, Jackline Gachoki, et al.
Science Translational Medicine|July 20, 2022
Improving the diagnosis of severe malaria in African children using platelet counts and plasma <i>Pf</i>HRP2 concentrationsJames A Watson, Sophie Uyoga, Perpetual Wanjiku, et al.
Wellcome Open Research|July 7, 2023
Mortality in rural coastal Kenya measured using the Kilifi Health and Demographic Surveillance System: a 16-year descriptive analysisMark Otiende, Evasius Bauni, Amek Nyaguara, et al.
Open Forum Infectious Diseases|March 20, 2026
Longitudinal Epidemiology and Variant Dynamics of SARS-CoV-2 in Coastal Kenya (2020-2025): Clinical Features and Wave PatternsArnold W Lambisia, Joyce Nyiro, George Githinji, et al.
Molecular Biology and Evolution|September 8, 2020
Evaluating the Performance of Malaria Genetics for Inferring Changes in Transmission Intensity Using Transmission ModelingOliver J Watson, Lucy C Okell, Joel Hellewell, et al.
BMC Medicine|July 12, 2014
A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccineMichael T White, Philip Bejon, Ally Olotu, et al.
Emerging Infectious Diseases|September 14, 2023
New SARS-CoV-2 Omicron Variant with Spike Protein Mutation Y451H, Kilifi, Kenya, March-May 2023Mike J Mwanga, Arnold W Lambisia, John Mwita Morobe, et al.
The Lancet. Infectious Diseases|April 9, 2018
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort studyAngela Huttner, Selidji Todagbe Agnandji, Christophe Combescure, et al.
Pageof 28